undamentalytics Newsletter
Sign in

Caredx, Inc. revenue

Caredx, Inc.'s revenue was $380m in fiscal 2025, up 13.8% on the year before. Since fiscal 2012 ($20.5m) it has grown at a compound 25.2% a year. Over the last twelve months it was $497m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue20222728414877127192296322280334380497
Growth on the year before—+8.1%+23.6%+3.1%+44.4%+18.9%+58.4%+66.0%+51.3%+54.2%+8.6%−12.9%+19.1%+13.8%—
Gross profit—————274482———————

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue Share YoY
Services $274M 72.3% ▲ 10.1%
Patient and Digital Solutions $56.9M 15.0% ▲ 30.5%
Products $48.4M 12.7% ▲ 18.6%
Geography
Region Revenue Share YoY
United States $360M 94.8% ▲ 13.3%
Outside the US $19.9M 5.2% ▲ 23.8%

From Caredx, Inc.'s 10-K filed February 25, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Services: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Caredx, Inc. $497m 38.9% 18.7%
Starling Oncology, Inc. $587m 38.4% 26.1%
U S Physical Therapy Inc $812m 11.3% 11.8%
Viemed Healthcare, Inc. $302m 25.2% 24.5%
Docgo Inc. $295m -32.4% -13.3%
DLH Holdings Corp. $254m -29.5% -9.5%

Compare with peers

Head to head: CDNA vs STLNCDNA vs USPHCDNA vs VMD

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Caredx, Inc.'s SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Caredx, Inc.